國聯證券(01456.HK):不再收購仍處於質押狀態的中融基金24.5%股權
格隆匯2月22日丨國聯證券(01456.HK)發佈公吿,有關公司擬收購中融基金100%股權、與上海融晟訂立股權轉讓協議及與中融信託訂立產權交易合同。鑑於上海融晟持有的中融基金剩餘24.5%股權仍處於質押狀態,公司於2023年2月22日與上海融晟簽署了《關於中融基金管理有限公司的股權轉讓協議之補充協議》,約定公司不再收購上述仍處於質押狀態的中融基金24.5%股權。
截至該公吿日期,根據公司與中融信託、上海融晟簽署的相關協議,公司收購中融基金的股權比例為75.5%。相關協議需待收購中融基金事宜獲中國證監會審批通過後方可生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.